MILLENNIUM MANAGEMENT LLC - DICERNA PHARMACEUTICALS INC ownership

DICERNA PHARMACEUTICALS INC's ticker is DRNA and the CUSIP is 253031108. A total of 113 filers reported holding DICERNA PHARMACEUTICALS INC in Q3 2019. The put-call ratio across all filers is - and the average weighting 0.5%.

Quarter-by-quarter ownership
MILLENNIUM MANAGEMENT LLC ownership history of DICERNA PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2021$7,282,000
-41.8%
361,222
+7.7%
0.00%
-50.0%
Q2 2021$12,520,000
+15.5%
335,486
-20.9%
0.01%0.0%
Q1 2021$10,839,000
+33.8%
423,889
+15.3%
0.01%
+33.3%
Q4 2020$8,102,000
+85.4%
367,783
+51.4%
0.01%
+20.0%
Q3 2020$4,369,000
-61.0%
242,864
-44.9%
0.01%
-66.7%
Q2 2020$11,198,000
-1.4%
440,856
-28.7%
0.02%
-42.3%
Q1 2020$11,354,000
-17.7%
618,085
-1.3%
0.03%
+52.9%
Q4 2019$13,789,000
+155.6%
625,910
+66.6%
0.02%
+88.9%
Q3 2019$5,394,000
-55.2%
375,640
-50.9%
0.01%
-50.0%
Q2 2019$12,039,000
+537.7%
764,394
+493.1%
0.02%
+500.0%
Q1 2019$1,888,000
+43.1%
128,877
+4.4%
0.00%
+50.0%
Q4 2018$1,319,000
-17.2%
123,423
+18.2%
0.00%0.0%
Q3 2018$1,593,000
+65.1%
104,414
+32.6%
0.00%
+100.0%
Q2 2018$965,000
-75.2%
78,765
-80.7%
0.00%
-80.0%
Q1 2018$3,896,000
+545.0%
407,530
+509.1%
0.01%
+400.0%
Q4 2017$604,000
+282.3%
66,907
+142.8%
0.00%
Q3 2017$158,000
+39.8%
27,559
-29.6%
0.00%
Q4 2016$113,000
-56.7%
39,140
-11.7%
0.00%
Q3 2016$261,000
+65.2%
44,322
-15.9%
0.00%
Q2 2016$158,000
+46.3%
52,693
+162.6%
0.00%
Q1 2016$108,000
-96.9%
20,064
-93.1%
0.00%
-100.0%
Q4 2015$3,473,000
+21.9%
292,560
-15.7%
0.01%
+16.7%
Q3 2015$2,849,000
-47.7%
347,044
-11.1%
0.01%
-40.0%
Q2 2015$5,447,000390,4640.01%
Other shareholders
DICERNA PHARMACEUTICALS INC shareholders Q3 2019
NameSharesValueWeighting ↓
Aquilo Capital Management, LLC 1,355,392$29,859,0006.21%
Bain Capital Life Sciences Investors, LLC 3,080,237$67,858,0004.26%
DAFNA Capital Management LLC 587,756$12,948,0003.85%
SILVERARC CAPITAL MANAGEMENT, LLC 227,388$5,009,0002.91%
RTW INVESTMENTS, LP 7,253,857$159,802,0002.68%
Parkman Healthcare Partners LLC 331,513$7,303,0001.87%
Evolutionary Tree Capital Management, LLC 60,864$1,341,0001.02%
Eagle Health Investments LP 69,000$1,520,0000.97%
Woodline Partners LP 1,358,796$29,934,0000.79%
Affinity Asset Advisors, LLC 40,000$881,0000.47%
View complete list of DICERNA PHARMACEUTICALS INC shareholders